Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredient

Food and Chemical Toxicology

Volumn 47, Issue 6, 2009, Pages 1231-1238

  Endres, J R ^a   Clewell, A ^a   Jade, K A ^a   Farber, T ^b   Hauswirth, J ^c   Schauss, A G ^a  

^a AIBMR Life Sciences Inc   (United States)

^b ToxaChemica International   (United States)

^c Van Gemert and Hauswirth LLC   (United States)

Author keywords

Bacillus coagulans; BC30; Functional foods; GRAS; Gut flora; Probiotics

Indexed keywords

GANEDENBC 30; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ACUTE DISEASE; AMES TEST; ANIMAL CELL; ARTICLE; BACILLUS COAGULANS; CHROMOSOMAL ABERRATION ASSAY; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; EYE IRRITATION; GENETIC PROCEDURES; GENOTOXICITY; HUMAN; IN VITRO STUDY; INNER CELL MASS; MICRONUCLEUS TEST; MOUSE; MOUTH DISEASE; MUTAGENIC ACTIVITY; NONHUMAN; RABBIT; RAT; RISK ASSESSMENT; SKIN IRRITATION; WISTAR RAT;

ANIMALS; BACILLUS; BLOOD CHEMICAL ANALYSIS; CHROMOSOME ABERRATIONS; EYE; FOOD; IRRITANTS; MALE; MICE; MICE, INBRED BALB C; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PROBIOTICS; RABBITS; RATS; RATS, WISTAR; SAFETY; SKIN; WEIGHT GAIN;

BACILLUS COAGULANS; BACTERIA (MICROORGANISMS); MUS; ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 67349098200     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.02.018     Document Type: Article

References (24)

1. Adami A., and Cavazzoni V. Occurrence of selected bacterial groups in the faeces of piglets fed with Bacillus coagulans as probiotic. J. Basic Microbiol. 39 (1999) 3-9
2. Ames B.N., et al. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 31 (1975) 347-364
3. Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am. J. Clin. Nutr. 73 (2001) 399S-405S
4. Buchanan R.E., and Gibbons N.E. Bergey's Manual of Determinative Bacteriology. eighth ed. (1974), Williams and Wilkens, Baltimore
5. De Clerck E., et al. Polyphasic characterization of Bacillus coagulans strains, illustrating heterogeneity within this species, and amended description of the species. Syst. Appl. Microbiol. 27 (2004) 50-60
6. De Vecchi E., and Drago L. Lactobacillus Sporogenes or Bacillus Coagulans: misidentification or mislabelling?. Int. J. Probiot. Prebiot. 1 (2006) 3-10
7. Donskey C.J., et al. Effect of oral Bacillus coagulans administration on the density of vancomycin-resistant enterococci in the stool of colonized mice. Lett. Appl. Microbiol. 33 (2001) 84-88
8. Gandhi A.B. Probiotic lactic acid bacteria. East. Pharm. 37 (1994) 43
9. Graff S., et al. Formulations for protecting the probiotic Saccharomyces boulardii from degradation in acidic condition. Biol. Pharm. Bull. 31 (2008) 266-272
10. Hyronimus B., et al. Acid and bile tolerance of spore-forming lactic acid bacteria. Int. J. Food Microbiol. 61 (2000) 193-197
11. Katsutoshi A.R., et al. Effect spore-bearing lactic acid-forming bacteria (Bacillus coagulans SANK 70258) administration on the intestinal environment, defecation frequency, fecal characteristics and dermal characteristics in humans and rats. Microbiol. Ecol. Health Dis. 14 (2003) 4-13
12. Lee Y.K. Handbook of Probiotics (1999), John Wiley & Sons, New York
13. Lesbros-Pantoflickova D., et al. Helicobacter pylori and probiotics. J. Nutr. 137 (2007) 812S-818S
14. Ljungh A., and Wadstrom T. Lactic acid bacteria as probiotics. Curr. Issues Intest. Microbiol. 7 (2006) 73-89
15. Maron D.M., and Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113 (1983) 173-215
16. McFarland L.V., and Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J. Gastroenterol. 14 (2008) 2650-2661
17. Ouwehand A.C. Antiallergic effects of probiotics. J. Nutr. 137 (2007) 794S-797S
18. Patel M.A., et al. Isolation and characterization of acid-tolerant, thermophilic bacteria for effective fermentation of biomass-derived sugars to lactic acid. Appl. Environ. Microbiol. 72 (2006) 3228-3235
19. Quigley E.M. Probiotics in irritable bowel syndrome: an immunomodulatory strategy?. J. Am. Coll. Nutr. 26 (2007) 684S-690S
20. Rastall R.A., et al. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiol. Ecol. 52 (2005) 145-152
21. Sanders M.E., et al. Lactobacillus sporogenes is not a Lactobacillus probiotic. ASM News. 67 (2001) 385
22. Sarles W.B., and Hammer B.W. Observations on Bacillus coagulans. J. Bacteriol. 23 (1932) 301-314
23. Spiller R. Review article: probiotics and prebiotics in irritable bowel syndrome. Alim. Pharmacol. Ther. 28 (2008) 385-396
24. Tappenden K.A., and Deutsch A.S. The physiological relevance of the intestinal microbiota-contributions to human health. J. Am. Coll. Nutr. 26 (2007) 679S-683S